v3.26.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Oct. 03, 2026
Sep. 27, 2025
Jun. 27, 2026
OPERATING ACTIVITIES:      
Net income (loss) $ 76.0 $ (21.4)  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation expense 10.3 9.8  
Amortization of acquired technologies and other intangibles 20.1 8.4  
Stock-based compensation 15.9 13.4  
Loss on debt extinguishment 0.0 3.8  
Amortization of debt issuance costs and accretion of debt discount 0.6 1.7  
Net change in fair value of contingent liabilities 12.4 10.9  
Deferred taxes, net 0.7 10.7  
Amortization of inventory step-up 0.0 2.6  
Restructuring (0.8) (0.3)  
Other (7.6) 1.3  
Changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable 15.1 17.4  
Inventories (22.4) (11.6)  
Other current and non-current assets (0.7) (0.5)  
Accounts payable 13.6 (0.5)  
Income taxes payable 2.2 0.8  
Deferred revenue, current and non-current (2.5) (10.7)  
Accrued payroll and related expenses (15.7) (9.1)  
Accrued expenses and other current and non-current liabilities (12.5) 4.3  
Net cash provided by operating activities 104.7 31.0  
INVESTING ACTIVITIES:      
Purchases of short-term investments (28.5) (0.9)  
Maturities of short-term investments 28.4 0.9  
Capital expenditures (12.0) (8.5)  
Proceeds from the sale of assets 0.8 0.9  
Acquisitions, net of holdbacks (11.9) 0.0  
Purchase price adjustment related to business acquisition 0.0 (0.7)  
Other investing activities 4.5 0.0  
Net cash used in investing activities (18.7) (8.3)  
FINANCING ACTIVITIES:      
Proceeds from issuance of debt 0.0 149.1  
Payment of debt and equity issuance costs (0.6) (7.8)  
Repurchase and retirement of common stock (150.0) (30.0)  
Withholding tax payment on vesting of restricted stock and performance- based awards (59.8) (16.2)  
Payment of financing obligations (0.1) (0.1)  
Proceeds from employee stock purchase plan 3.9 2.7  
Net cash (used in) provided by financing activities (206.6) 97.7  
Effect of exchange rates on cash, cash equivalents and restricted cash (1.0) (0.4)  
Net (decrease) increase in cash, cash equivalents and restricted cash (121.6) 120.0  
Cash, cash equivalents and restricted cash at the beginning of the period [1] 659.8 432.1 $ 432.1
Cash, cash equivalents and restricted cash at the end of the period $ 538.2 [2] $ 552.1 [2] $ 659.8 [1]
[1] These amounts include both current and non-current balances of restricted cash totaling $12.0 million and $8.5 million as of June 27, 2026 and June 28, 2025, respectively.
[2] These amounts include both current and non-current balances of restricted cash totaling $11.5 million and $8.3 million as of October 3, 2026 and September 27, 2025, respectively.